Citigroup’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,752
Closed -$64.5K 4874
2025
Q1
$64.5K Sell
14,752
-5,235
-26% -$22.9K ﹤0.01% 4036
2024
Q4
$93.3K Buy
19,987
+4,839
+32% +$22.6K ﹤0.01% 4030
2024
Q3
$106K Buy
15,148
+10,479
+224% +$73.6K ﹤0.01% 3970
2024
Q2
$32K Sell
4,669
-47,936
-91% -$329K ﹤0.01% 4092
2024
Q1
$744K Buy
+52,605
New +$744K ﹤0.01% 2580
2023
Q4
Sell
-47,669
Closed -$715K 4858
2023
Q3
$715K Buy
+47,669
New +$715K ﹤0.01% 2153
2022
Q4
Sell
-119
Closed -$1K 4938
2022
Q3
$1K Sell
119
-122
-51% -$1.03K ﹤0.01% 4769
2022
Q2
$3K Sell
241
-354
-59% -$4.41K ﹤0.01% 4965
2022
Q1
$8K Sell
595
-1,950
-77% -$26.2K ﹤0.01% 4828
2021
Q4
$45K Sell
2,545
-4,397
-63% -$77.7K ﹤0.01% 4345
2021
Q3
$151K Sell
6,942
-67,406
-91% -$1.47M ﹤0.01% 3506
2021
Q2
$2.6M Buy
74,348
+41,295
+125% +$1.45M ﹤0.01% 1905
2021
Q1
$3.26M Buy
33,053
+29,499
+830% +$2.91M ﹤0.01% 1624
2020
Q4
$385K Sell
3,554
-18,709
-84% -$2.03M ﹤0.01% 2805
2020
Q3
$2.29M Sell
22,263
-28,304
-56% -$2.92M ﹤0.01% 1452
2020
Q2
$10.6M Buy
50,567
+43,171
+584% +$9.01M 0.01% 755
2020
Q1
$723K Buy
7,396
+4,003
+118% +$391K ﹤0.01% 2042
2019
Q4
$391K Sell
3,393
-15,826
-82% -$1.82M ﹤0.01% 2790
2019
Q3
$1.05M Buy
19,219
+13,234
+221% +$721K ﹤0.01% 2085
2019
Q2
$711K Buy
5,985
+4,539
+314% +$539K ﹤0.01% 2418
2019
Q1
$75K Buy
1,446
+114
+9% +$5.91K ﹤0.01% 3760
2018
Q4
$42K Sell
1,332
-163
-11% -$5.14K ﹤0.01% 4021
2018
Q3
$90K Buy
1,495
+428
+40% +$25.8K ﹤0.01% 3668
2018
Q2
$57K Buy
+1,067
New +$57K ﹤0.01% 3778
2017
Q2
Sell
-228
Closed -$6K 4858
2017
Q1
$6K Sell
228
-2,287
-91% -$60.2K ﹤0.01% 4416
2016
Q4
$73K Buy
2,515
+1,443
+135% +$41.9K ﹤0.01% 4022
2016
Q3
$44K Buy
1,072
+133
+14% +$5.46K ﹤0.01% 3791
2016
Q2
$30K Sell
939
-1,193
-56% -$38.1K ﹤0.01% 3958
2016
Q1
$110K Buy
2,132
+1,340
+169% +$69.1K ﹤0.01% 3887
2015
Q4
$75K Buy
792
+594
+300% +$56.3K ﹤0.01% 3784
2015
Q3
$16K Sell
198
-7,337
-97% -$593K ﹤0.01% 4167
2015
Q2
$1.22M Buy
7,535
+5,982
+385% +$971K ﹤0.01% 1633
2015
Q1
$629K Buy
1,553
+947
+156% +$384K ﹤0.01% 2111
2014
Q4
$328K Buy
606
+554
+1,065% +$300K ﹤0.01% 2780
2014
Q3
$18K Buy
+52
New +$18K ﹤0.01% 4323